Metronidazole recall announced
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration date 05/2012…
Technology
Do you know which vaccines are recommended for special populations?
Pregnant and postpartum women, immunocompromised children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing Immunity to…
Issues up close
With the persistent focus on maintaining high childhood immunization rates, it’s easy to lose sight of the importance of adult immunization. But nurses must…
Placebos without deception effective for IBS
An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still experienced improvements,…
ECRI releases top 10 health technology hazards for 2011
ECRI Institute has released its Top 10 Lists of Health Technology Hazards for 2011: radiation therapy dose errors, alarm hazards, cross-contamination from flexible endoscopes,…
NIH plans new center for promoting drug development
A National Institute of Health (NIH) advisory board has approved the creation of National Center for Advancing Translational Sciences, a move intended to accelerate…
Propoxyphene taken off market
Xanodyne Pharmaceuticals, Inc., which makes Darvon and Darvocet, the brand versions of the prescription pain medication propoxyphene, has agreed to withdraw the medication from…
FDA approves new drug for schizophrenia
The U.S. Food and Drug Administration has approved Latuda (lurasidone HCL) tables for the treatment of adults with schizophrenia. Read more here.
New lupus drug one step closer to approval
An advisory panel has recommended the U.S. Food and Drug Administration approve Benlysta; it would be the first new drug approved to treat Lupus…
Do you know the schedule for vaccinating children?
Learn how to promote pediatric immunizations in your practice. Part of ANA’s Bringing Immunity to Every Community campaign. this handout stresses the importance of…
Issues up close
Awful day. Dealt with cranky, unreasonable pt with gross incision. Headed for *$. Gone are the “Dear Diary” days when one’s written frustrations or…
DPP-4 inhibitors: A new option for diabetes management
Drugs that inhibit dipeptidyl peptidase-4 (DPP-4) may improve glycemic control in patients with type 2 diabetes, reducing the risk of disease complications.
Metronidazole recall announced
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration…
Do you know which vaccines are recommended for special populations?
Pregnant and postpartum women, immunocompromised children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing…
Issues up close
With the persistent focus on maintaining high childhood immunization rates, it’s easy to lose sight of the importance of adult immunization. But…
Placebos without deception effective for IBS
An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still…
ECRI releases top 10 health technology hazards for 2011
ECRI Institute has released its Top 10 Lists of Health Technology Hazards for 2011: radiation therapy dose errors, alarm hazards, cross-contamination from…
NIH plans new center for promoting drug development
A National Institute of Health (NIH) advisory board has approved the creation of National Center for Advancing Translational Sciences, a move intended…
Propoxyphene taken off market
Xanodyne Pharmaceuticals, Inc., which makes Darvon and Darvocet, the brand versions of the prescription pain medication propoxyphene, has agreed to withdraw the…
FDA approves new drug for schizophrenia
The U.S. Food and Drug Administration has approved Latuda (lurasidone HCL) tables for the treatment of adults with schizophrenia. Read more here.
New lupus drug one step closer to approval
An advisory panel has recommended the U.S. Food and Drug Administration approve Benlysta; it would be the first new drug approved to…
Do you know the schedule for vaccinating children?
Learn how to promote pediatric immunizations in your practice. Part of ANA’s Bringing Immunity to Every Community campaign. this handout stresses the…
Issues up close
Awful day. Dealt with cranky, unreasonable pt with gross incision. Headed for *$. Gone are the “Dear Diary” days when one’s written…
DPP-4 inhibitors: A new option for diabetes management
Drugs that inhibit dipeptidyl peptidase-4 (DPP-4) may improve glycemic control in patients with type 2 diabetes, reducing the risk of disease complications.
Test Your Knowledge
food insecurity
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.